HighRes Biosolutions
Private Company
Total funding raised: $45M
Overview
HighRes Biosolutions is a US-based company that has evolved from a provider of reliable lab automation hardware to a developer of intelligent, AI-driven laboratory systems. Its core offering is the Cellario platform, which orchestrates hardware, software, workflows, and data into a seamless system, enabling scientists to execute complex experiments through natural language commands. The company targets the growing demand for scalable and accessible automation in life sciences, partnering with organizations to accelerate research in drug discovery, genomics, and synthetic biology.
Technology Platform
Cellario Lab Orchestration Platform: An integrated hardware and software platform featuring AI-powered lab assistants and agents for natural-language workflow creation and execution. It unifies modular automation systems, precision liquid handlers, and curated instruments.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
HighRes competes in the fragmented but consolidating lab automation market. It faces competition from large diversified life science tools companies (e.g., Thermo Fisher, Agilent, Danaher/Beckman) offering integrated systems, and from specialized software and robotics startups focusing on specific applications or AI. Its differentiation lies in its integrated hardware-software approach and focus on AI-driven accessibility.